Adding carboplatin fails to boost efficacy of docetaxel and trastuzumab: Comment

William J. Gradishar*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalOncology Report
Issue numberFALL
StatePublished - Sep 1 2006

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this